Introduction
Achalasia is an incurable primary progressive motility disorder of the esophagus where inhibitory ganglionic cells in the myenteric plexus of the lower esophageal sphincter (LES) are irreversibly lost. This leads to impaired relaxation of the LES after swallowing, causing functional obstruction. [1] [2] [3] [4] [5] [6] The most common symptoms of achalasia are dysphagia, heartburn, regurgitation, aspiration, and weight loss leading to impaired quality of life. [7] [8] [9] This clinical diagnosis is enhanced by barium swallow studies and endoscopy, and confirmed by manometry. 10 Although there is no curative treatment of achalasia, various therapies have been tried in the past without much success. [10] [11] [12] [13] [14] [15] New options for achalasia peroral endoscopic myotomy (POEM), selfexpanding metal stents, endoscopic sclerotherapy have shown promising results but there are only a few prospective observational studies to support their efficacy.
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Baniya et al comparing the success rate (improvement of dysphagia) of these procedures at short-term follow-up, 8, [24] [25] [26] but there are only 3 RCTs comparing the long-term outcomes at 5 years published till date. [27] [28] [29] Although there are systematic reviews and meta-analyses on prospective studies and non-RCTs, 30 there is only one meta-analysis of RCTs comparing the outcomes of these two procedures in the short-term. 31 Herein, we analyzed the published RCTs to study the short-and long-term success rates of these procedures in order to shed light on this controversial issue.
Methods
The Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement for reporting meta-analysis and systemic reviews 32 as recommended by the Cochrane Collaboration was used for this meta-analysis ( Figure 1) . A comprehensive electronic literature search was conducted for all the clinical trials on treatment of esophageal achalasia between the years 2000 and 2016 on PubMed, Embase, Scopus, Cochrane Library, clinicaltrials.gov, Ovid Medline, and Google scholar using the all-field "Achalasia, Esophageal", all-fields "Balloon dilation" or "Pneumatic dilation, and all-fields "Myotomy" or " Laparoscopic Heller's Myotomy" or "Laparoscopic esophageal myotomy"; all three search headings were connected with Boolean operator "AND". The eligibility criteria for the included studies relied on previously published guidelines for systematic reviews and were based on the PICO framework: P (Population: patients with idiopathic primary achalasia diagnosed with the help of clinical, endoscopic and manometric, and radiographic evidence), I (Intervention: repeated BD/PD), C (Comparative intervention/control group: LEM/Heller's myotomy), and O (Outcomes: improvement in dysphagia score). Only RCTs published in English were included. Patients were randomly assigned to PD or LEM group. Studies with at-least 3-month follow-up were included. Two reviewers (RB and SU) independently assessed the eligibility and validity of each study. Any disagreements were resolved with discussion with the Figure 1 PrisMa statement of the study. Abbreviation: PrisMa, Preferred reporting items for systematic reviews and Meta-analysis.
Additional records identified
through other sources (n = 7)
Records after duplicates removed (n = 287)
Records screened (n = 13)
Records excluded (n = 5)
Full-text articles assessed for eligibility (n = 8) From all the selected studies, we extracted the baseline study details (Table 2) : total number of patient enrolled, number of patients in each arm, mean age, sex ratio, inclusion and exclusion criteria, procedure detail (Tables 3 and 4) , randomization process, definition of success or failure, adverse events, and quality of life score. Success rate was measured at 3 months, 1 year, and 5 years. The outcomes were calculated with RevMan, version 5.2 for Windows (Cochrane Collaboration, Oxford, UK). Analysis was performed by Mantel-Haenszel test. Odds ratio (OR) was calculated using confidence interval (CI) of 95%. Heterogeneity was (Table 5) .
Results
A total of 437 patients at 3-month interval, 378 patients at 1-year interval, and 254 patients at 5-year interval were analyzed for success rate of the procedure, namely the improvement in the dysphagia score. 
Discussion
Achalasia is a primary motor disorder of the esophagus that is chronic and incurable. Although LEM and PD are the mainstays of treatment, the best modality remains controversial. 4 Both treatment approaches carry a variable risk of recurrence of symptoms, perforation, and gastrointestinal reflux. 38 Therefore, it is imperative to identify the best method for the Myotomy (involving division of the entire muscle layer down to the mucosa about 5 cm above the gastroesophageal junction and 2-3 cm in the proximal stomach) plus toupet (partial) fundoplication to prevent reflux. hamdy et al 26 Myotomy starting just above the point of apparent constriction until the place between the muscle and the mucosa identified. Myotomy extended 6 cm in the lower esophagus and 2 cm in the proximal stomach. Dor's fundoplication to prevent reflux. Moonen et al 28 Myotomy performed extending at least 6 cm above the gastroesophageal junction and up to 1.5 cm on proximal stomach followed by anterior 180 degree Dor's fundoplication. Borges et al 37 heller laparoscopic myotomy performed with circular and longitudinal myotomy of 6 cm extending to distal esophagus and 2 cm into proximal stomach. novais and lemme 25 anesthesia: general anesthesia. Procedure: sectioning the longitudinal and circular muscular muscle layer involving distal 6 cm of esophagus and 2 cm proximal stomach followed by 180 degree anterior fundoplication. Demeester's grading of dysphagia assessing successful symptomatic relief.
1. recurrent symptoms after surgery was considered failure. 2. Pneumatic dilation was considered failure if more than 3 sets of dilations was needed. Moonen et al 28 The European achalasia trial Therapeutic success based on presence of Eckardt score ≤3.
1. if Eckardt score remained >3 at 4 weeks after the index dilation. 2. redilation allowed twice (second and third series) but the third dilation allowed for recurrence after 2 years only. if third dilation required before 2 years, then it was considered a failure. 3. For laparoscopic myotomy, Eckardt score >3 was considered a failure. Borges et al 37 Clinical improvement based on Vantrappen and hellemans score for dysphagia.
1. Poor responder defined under fair results (dysphagia for one or two times/week, associated with food regurgitation, without weight loss) and poor results (dysphagia over twice a week, regurgitation and weight loss). novias and lemme 25 Vantrappen and hellemans criteria for dysphagia response.
1. Excellent result: absence of dysphagia. 2. Good: occasional dysphagia, less than once a week. 3. Fair: dysphagia more than once a week, associated with regurgitation. 4. Poor: dysphagia more than once a week, associated with regurgitation and weight loss. 5. Considered failure if fair or poor response.
Abbreviation: rCT, randomized controlled trial. Hamdy et al 26 Moonen et al 28 Novais and Lemme 25 Total events Heterogeneity: Tau 2 = 0.00; Chi 2 = 1.97, df = 3 (P = 0.58); I = 0% Test for overall effect: Z = 2.60 (P = 0.009)
Total (95% CI)
Study or subgroup
Borges et al 38 Hamdy et al 26 Moonen et al 28 Persson et al 27 Total events Heterogeneity: Tau 
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Baniya et al short-and long-term symptom relief with due consideration of complications. Our study compared the short-and longterm outcomes of the two procedures based on symptom relief at 3 different intervals. Our analysis shows that LEM is better at 3 months and at 1 year (with increasing confidence interval), while PD becomes non-inferior to LEM at 5 years. These results indicate that both treatment approaches lead to comparable outcomes in the long run.
In contrast to LEM, one major advantage of PD is that it can be performed safely in the outpatient setting without need for general anesthesia. However, more patients in single PD group require re-intervention compared to those treated with LEM. 39 Although the remission rate is higher with graded dilation approach, [40] [41] [42] [43] it is associated with higher rates of perforation and complex surgery 44 LEM, on the other hand, has the major risk of mucosal tear, and leads to abdominal wall trauma requiring longer recovery time.
In a meta-analysis by Yaghoobi et al, 31 LEM provided greater relief of symptoms compared to graded dilation. The main limitation of the study was the lack of long-term follow-up and a small number of included studies. The network meta-analysis by Schoenberg et al 45 corroborated these findings. The study did not include long-term follow-up and included indirect comparison. In another meta-analysis by Campos et al, 30 LEM was found to be more effective and long lasting compared to BD or botulin toxin injection. However, the complication rate was higher in the surgical group due to the invasiveness of the procedure. In this regard, PD was deemed more suited for frail patients who are poor surgical candidates, or for those patients who fail surgery. However, the results of these studies have to be interpreted with caution as these studies often use variable and subjective definitions of success rate. Furthermore, some of the studies included in the analysis used data from single dilations, while it is well known that it is a multistage procedure with graded dilation. 46 In lieu of the largest RCT, the European Achalasia Trial, 28 the present meta-analysis is the only one of its kind to include this in the analysis.
The other consideration for this study is the evolving technique of the procedure. The technique of dilation has evolved from rigid dilators to hydrostatic balloon. This allows achievement of maximum controlled volume with low pressure, which improves efficacy and prevents perforation. 47 The hypothesis that BD causes the disruption of muscular layer has been challenged by the study by Borhan-Manesh et al. 48 The finding shows that PD works by circumferential stretching of the LES. This has resulted in modification of the current method of dilation by slowing the rate of inflation, leading to increased remission rate of BD. POEM is a newer technique that is being used to perform myotomy of the LES. Long-term data from RCTs comparing POEM with conventional treatment methods are lacking. This procedure is still evolving and its role in management of achalasia is not clearly outlined. 49 Further studies comparing conventional treatment with POEM with a longer follow-up will be needed for change in practice. Thus, PD or LEM continues to remain the standard of care for achalasia with comparable outcome in the long-term.
Conclusion
Taken together, the data presented here provide evidence that both treatments have similar success rate at 5 years. So, eligible patients should be given the option of PD or LEM at this time.
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